← Open Payments lookup

NYMPHA DALGADO: Open Payments

NPI 1982731154 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,163 in 36 payments from 6 companies in 2025. Trend: 2023 $1,360 · 2024 $1,914 · 2025 $1,163

Food & beverage: $1,163
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$460
ABBVIE INC.8$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$194
Vanda Pharmaceuticals Inc.6$154
Teva Pharmaceuticals USA, Inc.1$117
E.R. Squibb & Sons, L.L.C.1$22

Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, UZEDY, ABILIFY MAINTENA, HETLIOZ, ABILIFY ASIMTUFII.

Industry payments across VA — which companies pay providers there.